Becton Dickinson buys developer of rapid "superbug" test for $230m
This article was originally published in Clinica
Executive Summary
Becton Dickinson (BD) has agreed to acquire GeneOhm Sciences, the San Diego, California company claimed to be the "pioneer" of rapid, DNA testing for bacterial organisms, for $230m. Along with the upfront payment, the agreement also provides GeneOhm with additional incentives of up to $25m.